SUZ12-核酸相互作用限制PRC2活动,以维持向基因沉默,这对于扩散中线质瘤至关重要
bioRxiv : the preprint server for biology
|July 25, 2025
概括
聚合物抑制复合物2 (PRC2) 的活性由其与核酸相互作用的SUZ12子单元调节. 这种相互作用限制了PRC2.
科学领域:
- 表观遗传学和基因调控
- 癌症生物学 癌症生物学
- 分子瘤学分子瘤学
背景情况:
- 聚合体抑制复合体2 (PRC2) 建立了H3K27me3标记,对发育至关重要,在癌症中经常失调.
- 患有H3 K27M突变的儿科扩散中线质瘤 (DMGs) 显示全球H3K27me3损失,但仍依赖于残留的PRC2活性.
- 这种残留的PRC2酶功能的精确调节仍然不太清楚.
研究的目的:
- 阐明控制H3 K27M突变质瘤残留PRC2活性及其调节的分子机制.
- 研究SUZ12子单元在PRC2的催化功能和染色体向中的作用.
主要方法:
- 调查了SUZ12 N-终端区域在PRC2监管中的作用.
- 表达了一种截断的SUZ12变体,缺乏核酸结合元件.
- 进行生物化学分析并评估H3K27me3水平,PRC1复合体位移,染色体结构和细胞生长in vitro和in vivo .
主要成果:
- 确定了SUZ12 N-终端区域作为一个通过短暂的核酸相互作用限制PRC2活性的调节域.
- 截断的SUZ12的表达导致了广泛的H3K27高甲基化,PRC1位移,染色质破坏和质瘤细胞生长受损.
- 生物化学分析证实了SUZ12通过非生产性核酸结合来调节PRC2活性,从而建立了动力平衡.
结论:
- PRC2的特异性取决于生产性核体参与和非生产性核酸相互作用之间的动态平衡.
- SUZ12 N端域在调节PRC2向和活动方面发挥着关键作用.
- 结果提供了对PRC2调节的见解,并确定了PRC2-依赖癌症的潜在治疗漏洞.
更多相关视频
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
645
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
5.7K
相关概念视频
Experimental RNAi
6.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
siRNA - Small Interfering RNAs
17.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.0K
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
RNA Interference
26.5K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.5K
piRNA - Piwi-interacting RNAs
7.0K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.0K
